Altimmune Statistics
NASDAQ: ALTHealth CareBiotechnology: Pharmaceutical PreparationsUSD
2.66-0.01 (-0.37%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
After hours: 2.66 0.00%
Altimmune by the numbers
Altimmune has a market capitalization of $517.4 million based on 194.52M shares outstanding. With trailing EPS of $-0.76, Altimmune is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 13.6% below its 50-day average and 22.6% below its 200-day average.
Average daily trading volume is 4.19M shares, or about $11.1 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
ALT valuation vs. peer median
| Metric | ALT | Peer median | Difference |
|---|---|---|---|
| Market cap | $517.42M | $515.31M | +0% |
| Avg. volume | 4.19M | 293.43K | +1327% |
Peer median across 8 companies: MPLT, NGNE, OCS, DRUG, EOLS, BLSM, PBYI, CBIO.
Valuation
- Market cap
- $517.42M
- EPS (TTM)
- $-0.76
- Shares outstanding
- 194.52M
Price and trading
- Previous close
- 2.67
- Open
- 2.64
- Day range
- 2.63 – 2.74
- 52-week range
- 2.56 – 6.44
- 52-week change
- -32.32%
- Beta
- —
- Volume
- 3.16M
- Average volume
- 4.19M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 5, 2026
Additional statistics
- Market Cap
- 517.42M
- Forward Pe
- -3.98
- Eps
- -0.76
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 6.44
- Week52 Low
- 2.56
- Avg Volume
- 4.19M
- Shares Outstanding
- 194.52M
- Ma50
- 3.08
- Ma200
- 3.44
- Earnings Date
- Nov 5, 2026
- Pct From52w High
- -58.70%
- Pct From52w Low
- 3.91%